Charles Schwab Investment Management Inc Cure Vac N.V. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$14.73 - $35.25 $91,974 - $220,101	-6,244 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$33.72 - $48.22 $11,161 - $15,960	331 Added 5.6%	6,244 $215,000
Q3 2021 Nov 16, 2021	BUY	$49.26 - $74.5 $16,748 - $25,330	340 Added 6.1%	5,913 $323,000
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $317,159 - $710,724	5,573 New	5,573 $410,000

12.2M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $716M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.